The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).

Artemisinin-based combination therapies (ACTs) have been recommended by the World Health Organization (WHO) as first-line treatment of uncomplicated Plasmodium falciparum (P. falciparum) malaria since 2005 in Democratic Republic of Congo (DRC) and a regular surveillance of the ACT efficacy is requir...

Full description

Bibliographic Details
Main Authors: Doudou Malekita Yobi, Nadine Kalenda Kayiba, Dieudonné Makaba Mvumbi, Raphael Boreux, Sebastien Bontems, Pius Zakayi Kabututu, Patrick De Mol, Niko Speybroeck, Georges Lelo Mvumbi, Marie-Pierre Hayette
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0237791
_version_ 1819012304516153344
author Doudou Malekita Yobi
Nadine Kalenda Kayiba
Dieudonné Makaba Mvumbi
Raphael Boreux
Sebastien Bontems
Pius Zakayi Kabututu
Patrick De Mol
Niko Speybroeck
Georges Lelo Mvumbi
Marie-Pierre Hayette
author_facet Doudou Malekita Yobi
Nadine Kalenda Kayiba
Dieudonné Makaba Mvumbi
Raphael Boreux
Sebastien Bontems
Pius Zakayi Kabututu
Patrick De Mol
Niko Speybroeck
Georges Lelo Mvumbi
Marie-Pierre Hayette
author_sort Doudou Malekita Yobi
collection DOAJ
description Artemisinin-based combination therapies (ACTs) have been recommended by the World Health Organization (WHO) as first-line treatment of uncomplicated Plasmodium falciparum (P. falciparum) malaria since 2005 in Democratic Republic of Congo (DRC) and a regular surveillance of the ACT efficacy is required to ensure the treatment effectiveness. Mutations in the propeller domain of the pfk13 gene were identified as molecular markers of artemisinin resistance (ART-R). This study investigated the pfk13-propeller gene polymorphism in clinical isolates of P. falciparum collected in the DRC. In 2017, ten geographical sites across DRC were selected for a cross-sectional study that was conducted first in Kinshasa from January to March, then in the nine other sites from September to December. Dried blood samples were collected from patients attending health centers for fever where diagnosis of Malaria was first made by rapid diagnostic test (RDT) available on site (SD Bioline malaria Ag Pf or CareStart Malaria Pf) or by thick blood smear and then confirmed by a P. falciparum real-time PCR assay. A pfk13-propeller segment containing a fragment that codes for amino acids at positions 427-595 was amplified by conventional PCR before sequencing. In total, 1070 patients were enrolled in the study. Real-time PCR performed confirmed the initial diagnosis of P. falciparum infection in 806 samples (75.3%; 95% CI: 72.6%- 77.9%). Of the 717 successfully sequenced P. falciparum isolates, 710 (99.0%; 95% CI: 97.9% - 99.6) were wild-type genotypes and 7 (1.0%; 95% CI: 0.4% - 2.1%) carried non-synonymous (NS) mutations in pfk13-propeller including 2 mutations (A578S and V534A) previously detected and 2 other (M472I and A569T) not yet detected in the DRC. Mutations associated with ART-R in Southeast Asia were not observed in DRC. However, the presence of other mutations in pfk13-propeller gene calls for further investigations to assess their implication in drug resistance.
first_indexed 2024-12-21T01:41:56Z
format Article
id doaj.art-256d582b5e16492599cc038668e11bcd
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T01:41:56Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-256d582b5e16492599cc038668e11bcd2022-12-21T19:20:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01158e023779110.1371/journal.pone.0237791The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).Doudou Malekita YobiNadine Kalenda KayibaDieudonné Makaba MvumbiRaphael BoreuxSebastien BontemsPius Zakayi KabututuPatrick De MolNiko SpeybroeckGeorges Lelo MvumbiMarie-Pierre HayetteArtemisinin-based combination therapies (ACTs) have been recommended by the World Health Organization (WHO) as first-line treatment of uncomplicated Plasmodium falciparum (P. falciparum) malaria since 2005 in Democratic Republic of Congo (DRC) and a regular surveillance of the ACT efficacy is required to ensure the treatment effectiveness. Mutations in the propeller domain of the pfk13 gene were identified as molecular markers of artemisinin resistance (ART-R). This study investigated the pfk13-propeller gene polymorphism in clinical isolates of P. falciparum collected in the DRC. In 2017, ten geographical sites across DRC were selected for a cross-sectional study that was conducted first in Kinshasa from January to March, then in the nine other sites from September to December. Dried blood samples were collected from patients attending health centers for fever where diagnosis of Malaria was first made by rapid diagnostic test (RDT) available on site (SD Bioline malaria Ag Pf or CareStart Malaria Pf) or by thick blood smear and then confirmed by a P. falciparum real-time PCR assay. A pfk13-propeller segment containing a fragment that codes for amino acids at positions 427-595 was amplified by conventional PCR before sequencing. In total, 1070 patients were enrolled in the study. Real-time PCR performed confirmed the initial diagnosis of P. falciparum infection in 806 samples (75.3%; 95% CI: 72.6%- 77.9%). Of the 717 successfully sequenced P. falciparum isolates, 710 (99.0%; 95% CI: 97.9% - 99.6) were wild-type genotypes and 7 (1.0%; 95% CI: 0.4% - 2.1%) carried non-synonymous (NS) mutations in pfk13-propeller including 2 mutations (A578S and V534A) previously detected and 2 other (M472I and A569T) not yet detected in the DRC. Mutations associated with ART-R in Southeast Asia were not observed in DRC. However, the presence of other mutations in pfk13-propeller gene calls for further investigations to assess their implication in drug resistance.https://doi.org/10.1371/journal.pone.0237791
spellingShingle Doudou Malekita Yobi
Nadine Kalenda Kayiba
Dieudonné Makaba Mvumbi
Raphael Boreux
Sebastien Bontems
Pius Zakayi Kabututu
Patrick De Mol
Niko Speybroeck
Georges Lelo Mvumbi
Marie-Pierre Hayette
The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
PLoS ONE
title The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
title_full The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
title_fullStr The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
title_full_unstemmed The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
title_short The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
title_sort lack of k13 propeller mutations associated with artemisinin resistance in plasmodium falciparum in democratic republic of congo drc
url https://doi.org/10.1371/journal.pone.0237791
work_keys_str_mv AT doudoumalekitayobi thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT nadinekalendakayiba thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT dieudonnemakabamvumbi thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT raphaelboreux thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT sebastienbontems thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT piuszakayikabututu thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT patrickdemol thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT nikospeybroeck thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT georgeslelomvumbi thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT mariepierrehayette thelackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT doudoumalekitayobi lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT nadinekalendakayiba lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT dieudonnemakabamvumbi lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT raphaelboreux lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT sebastienbontems lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT piuszakayikabututu lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT patrickdemol lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT nikospeybroeck lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT georgeslelomvumbi lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc
AT mariepierrehayette lackofk13propellermutationsassociatedwithartemisininresistanceinplasmodiumfalciparumindemocraticrepublicofcongodrc